New Delhi: Covaxin, the indigenously developed COVID-19 vaccine, has demonstrated protective efficacy and immunogenicity in non-human primates in Phase I clinical trials in India. Covaxin, which is developed by Bharat...
Bhubaneswar: Facing a massive shortage of ICU beds, the Odisha capital has emerged a COVID-19 hotspot with 400 cases being reported almost daily. With the affected tally crossing the 15,000-mark...
Bhubaneswar: The Directorate of Drugs Control, Odisha on Saturday set certain conditions as per the directives of the Drugs Controller General India (DCGI) for retail sale of the COVID drugs....
Bhubaneswar: Eleven more patients succumbed to COVID-19 in Odisha in the last 24 hours, taking the toll to 616 on Saturday. The new deaths included three from Cuttack district and...
Bhubaneswar: With 3777 new COVID-19 positive cases reported in the state in the last 24 hours, the tally went up to 146894. Of the new cases reported from all 30...
New Delhi: Delhi Metro resumed full services on Saturday with the Airport Express Line operating after more than 170 days due to COVID-19 induced Lockdown. Metro network’s all corridors of...
Balasore: Chief Secretary Asit Tripathy has directed the Balasore district administration to set up a 100-bed COVID Hospital on the premises of the district headquarters hospital. The new hospital will...
Bhubaneswar: As many as 50,979 COVID-19 tests were conducted in Odisha in the last 24 hours, the State Health & Family Welfare (H&FW) Department informed on Saturday. These included 7,607...
Rourkela: Rourkela alone has reported 60 of the 88 new COVID-19 cases in Odisha’s Sundargarh district that pushed the district’s tally to 5350 on Friday. The rest of the cases...
New Delhi: With pharma giant AstraZeneca pausing the Oxford COVID-19 vaccine candidate's trials in other countries, the Serum Institute of India (SII) has been suspended by the Drugs Controller General...